Correlation Between Bank of America and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Mereo BioPharma Group, you can compare the effects of market volatilities on Bank of America and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Mereo BioPharma.

Diversification Opportunities for Bank of America and Mereo BioPharma

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bank and Mereo is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Bank of America i.e., Bank of America and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Bank of America and Mereo BioPharma

Considering the 90-day investment horizon Bank of America is expected to generate 4.55 times less return on investment than Mereo BioPharma. But when comparing it to its historical volatility, Bank of America is 3.2 times less risky than Mereo BioPharma. It trades about 0.06 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Mereo BioPharma Group on August 27, 2024 and sell it today you would earn a total of  290.00  from holding Mereo BioPharma Group or generate 353.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bank of America  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bank of America and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Mereo BioPharma

The main advantage of trading using opposite Bank of America and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Bank of America and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance